According to global statistics, cancer is the second leading cause of death worldwide (Carlson et al., 2012). WHO estimates that by the year 2050, there will be 27 million new occurrences and 17.5 million deaths from cancer (Torre et al., 2015). Anticancer agents such as doxorubicin, paclitaxel, and cisplatin present many limitations that hinder the effectiveness of chemotherapy. These limitations include poor solubility in aqueous solutions, non-specific distribution

No abstract

No abstract

No abstract